275 related articles for article (PubMed ID: 32533350)
1. Optimizing the Timing and Composition of Therapeutic Phage Cocktails: A Control-Theoretic Approach.
Li G; Leung CY; Wardi Y; Debarbieux L; Weitz JS
Bull Math Biol; 2020 Jun; 82(6):75. PubMed ID: 32533350
[TBL] [Abstract][Full Text] [Related]
2. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
[TBL] [Abstract][Full Text] [Related]
3. Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.
Bull JJ; Levin BR; Molineux IJ
Viruses; 2019 Nov; 11(12):. PubMed ID: 31766537
[TBL] [Abstract][Full Text] [Related]
4. Phage therapy administered noninvasively could be effective in thin tubes subject to episodic flow despite washout: a simulation study.
Blanco C; Chen IA
Phys Biol; 2019 Jul; 16(5):054001. PubMed ID: 31266001
[TBL] [Abstract][Full Text] [Related]
5. Modeling the synergistic elimination of bacteria by phage and the innate immune system.
Leung CYJ; Weitz JS
J Theor Biol; 2017 Sep; 429():241-252. PubMed ID: 28668337
[TBL] [Abstract][Full Text] [Related]
6. Back to the future: bacteriophages as promising therapeutic tools.
Domingo-Calap P; Georgel P; Bahram S
HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
[TBL] [Abstract][Full Text] [Related]
7. Phage therapy for respiratory infections.
Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
Dąbrowska K; Abedon ST
Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
[TBL] [Abstract][Full Text] [Related]
9. Phages and their potential to modulate the microbiome and immunity.
Federici S; Nobs SP; Elinav E
Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriophages in the battle against multidrug resistant bacteria].
van der Meer JWM; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
[TBL] [Abstract][Full Text] [Related]
11. Combatting intracellular pathogens using bacteriophage delivery.
Goswami A; Sharma PR; Agarwal R
Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
[TBL] [Abstract][Full Text] [Related]
12. PhREEPred: Phage Resistance Emergence Prediction Web Tool to Foresee Encapsulated Bacterial Escape from Phage Cocktail Treatment.
Smug BJ; Majkowska-Skrobek G; Drulis-Kawa Z
J Mol Biol; 2022 Jul; 434(14):167670. PubMed ID: 35671831
[TBL] [Abstract][Full Text] [Related]
13. Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens.
Farooq T; Hussain MD; Shakeel MT; Tariqjaveed M; Aslam MN; Naqvi SAH; Amjad R; Tang Y; She X; He Z
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215763
[TBL] [Abstract][Full Text] [Related]
14. Towards Inhaled Phage Therapy in Western Europe.
Wienhold SM; Lienau J; Witzenrath M
Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
16. Implications of lytic phage infections inducing persistence.
Sanchez-Torres V; Kirigo J; Wood TK
Curr Opin Microbiol; 2024 Jun; 79():102482. PubMed ID: 38714140
[TBL] [Abstract][Full Text] [Related]
17. Bacteriophage-mediated modulation of microbiota for diseases treatment.
Zhang Y; Li CX; Zhang XZ
Adv Drug Deliv Rev; 2021 Sep; 176():113856. PubMed ID: 34237403
[TBL] [Abstract][Full Text] [Related]
18. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong T; Salabarria AC; Roach DR
Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
[TBL] [Abstract][Full Text] [Related]
19. Phage therapy for severe bacterial infections: a narrative review.
Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
[TBL] [Abstract][Full Text] [Related]
20. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
Royer S; Morais AP; da Fonseca Batistão DW
Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
